Skip to main content
. 2020 Feb 6;9(2):102. doi: 10.3390/pathogens9020102

Figure 2.

Figure 2

Sera reactivity to BL fractions. Western-Blot analysis of the BLs fractions resolved in a 12% SDS-PAGE, transferred to a PVDF membrane and incubated with the sera of patients (a) post-treatment and (b) donors with no UTIs. MW: molecular weight marker; lanes 1-6: O75 BL, O25 BL, O6 BL, O8 BL, CFT073 BL, and HB101 BL, respectively. Highly immunogenic fractions with post-treatment and donor sera are inside the white square.